Proqr Therapeutics Nv

Penny Stocks Biotech Stocks Healthcare Stocks

$1.36

+0.10 (+7.94%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +576.5% upside

Low Target $6.27

Average Target $9.20

High Target $10.38

Current Price $1.36

Current
$1.36

Target
$9.20

$6.27 $9.20 avg $10.38

Scenario Analysis

Bear Case

$6.27

361.0%

Low target

Base Case

$9.20

+576.5%

Avg target

Bull Case

$10.38

+663.2%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.51

-45.8% from high

52-Week Low

$1.20

+13.3% from low

Target vs 52W High

$9.20

+266.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.5%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%